NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc.: A Big Shift to Stablecoins

Hey everyone, let's break down some recent news about NovaBay Pharmaceuticals, Inc. in a way that makes sense, without all the fancy finance talk. Think of this as me explaining it to you over coffee.

1. What happened?

So, here's the big news: NovaBay Pharmaceuticals announced a complete and immediate shift in its business focus, leaving its old pharmaceutical business behind. It will change its name to "Stablecoin Development Corporation" and its stock ticker symbol to "SDEV." This is a huge change, not just a small update. It transforms the company's core identity and how it operates.

They also shared a lot of details about their dive into the world of cryptocurrency:

• They received a large $134 million investment from key players in the crypto space. These include R01 Fund LP, Framework Ventures, and Sky Frontier Foundation. Tether Investments (which is linked to USDT, the world's biggest stablecoin) also invested. This big cash injection supports their new plan.
• They now hold about 2.06 billion SKY tokens as of March 16, 2026. This is about 8.78% of all SKY tokens available. SKY tokens are used for voting and other functions of the Sky Protocol. This is a digital finance platform that builds stablecoins, especially USDS.
• They've already earned about 26.6 million SKY tokens in rewards by "staking" these tokens. Staking is like earning interest or rewards by holding and supporting a crypto network. In this case, it supports the Sky Protocol.
• They got these SKY tokens in two ways. About 943.6 million SKY tokens were part of the first $134 million investment, valued at $58 million. They also used $70.7 million from that investment. This bought another 1.09 billion SKY tokens on the open market. Each token cost about $0.065 on average.

2. When did it happen?

This all happened on March 23, 2026. The company announced these big changes in a press release. The name change to "Stablecoin Development Corporation" and new ticker "SDEV" will become official on April 3, 2026. This is when trading starts. This fresh news should immediately impact the stock. The market will re-evaluate the company's new identity and business model.

3. Why did it happen?

To understand why this happened, let's look back a bit. NovaBay completely changes its business model. This likely happened because its old pharmaceutical business faced challenges and slow growth. They are jumping into crypto and blockchain. Their focus is on building stablecoins and acting as an "on-chain holding company." This is a strategic move. They see more growth and innovation in this new market.

The CEO, Michael Kazley, said it clearly. He believes stablecoins offer "the best opportunity in digital finance." They want to be "the top public company to tap into the growing stablecoin economy's money flow." This goal links to their work with the Sky Protocol and its USDS stablecoin. They want to profit from the rising demand for stable digital assets.

The big $134 million private investment powers this change. They use this money to become an "on-chain holding company." This means they will buy and hold many digital assets for a long time. For example, they hold 2.06 billion SKY tokens. Their main goal is to join the economic activity and governance of these crypto networks. They aim to earn money through staking rewards, like the 26.6 million SKY tokens already earned. They also hope their digital assets will grow in value. They might also sell some holdings over time. This would fund company operations or give money back to shareholders. They will manage the risks of the volatile digital asset market. This is a radical new path. It's a strategic choice to seize high-growth chances in digital assets. They are moving away from traditional pharmaceutical challenges.

4. Why does this matter?

Okay, so why should you care about this? It's a big deal. NovaBay is no longer a pharmaceutical company. If you own NBY stock, your investment is now fully in a crypto-focused company. This includes stablecoins and the Sky Protocol. This completely changes the company's risk and reward profile.

• Complete Identity Shift: This changes the company's identity, growth potential, and risk profile. Investors now face crypto's high volatility and uncertain regulations. This differs from the slower, but often more predictable, drug industry.
• Massive Crypto Exposure: They hold 2.06 billion SKY tokens (about 8.78% of the total supply!). They actively stake these tokens. Their financial results will depend heavily on SKY's value and performance. It also depends on the Sky Protocol's success and the wider crypto market. This big focus on one digital asset means SDEV's value will react strongly to changes in SKY's price. It also depends on the Sky Protocol's health. The 26.6 million SKY tokens already earned from staking show this is a new, active way to make money. It adds directly to their operating cash.
• Institutional Backing: Investors like Tether Investments are involved. This is a big sign of approval. Tether is linked to USDT, the world's largest stablecoin. Their investment suggests they strongly believe in SDEV's new path. They also believe in the Sky Protocol's viability and its potential to be a key stablecoin player. This backing from big institutions could make SDEV's bold change more credible.
• Managing Volatility: The company set rules for new investors who got warrants (rights to buy shares later). These rules stop them from selling all their shares at once. They can only sell up to 10% of SDEV's average daily trading volume each day. This aims for a more "orderly market." It prevents big price swings from large sales. This shows a focus on long-term stability, not quick exits.

This kind of event can really change the company's future direction. It also changes how investors see its value.

5. Who is affected?

Who's feeling the ripple effect from this? Pretty much everyone connected to NovaBay, but especially:

• Investors (that's us!): This is the biggest impact. If you bought NovaBay for drugs, you now own a crypto company. The stock price could swing wildly. This depends on how the market reacts to this huge change. It also depends on their new crypto ventures' performance. Your whole investment reason has changed.
• The Company Itself: This completely transforms its business. It needs new skills, strategies, and maybe a very different structure. They're now focused on the Sky Protocol ecosystem. SKY tokens are their core holding.
• Customers: Old drug customers for products like Avenova® and CelleRx® won't feel the new business impact right away. But NovaBay's traditional drug lines now have a very uncertain future. The filing doesn't say this clearly. But the "complete pivot" suggests they will stop, sell off, or greatly reduce their old drug business. New "customers" for Stablecoin Development Corporation will be crypto users. They will engage with the Sky Protocol and its USDS stablecoin.
• Employees: The filing doesn't mention employees. But such a big change often means staff changes. Some jobs become old, and new ones are created for the new business.
• The Sky Protocol Ecosystem: SDEV is now a big player. It holds a large part (8.78%) of all SKY tokens. Their actions could notably affect the Sky Protocol.

6. What happens next?

So, what's on the horizon? What can we expect to see unfold?

• Immediately: The stock will likely react when the market opens on March 25th. This is the next trading day after the announcement.
• Short-term: The company officially changes its name to "Stablecoin Development Corporation" and its ticker to "SDEV" on April 3, 2026. Expect more details on their "on-chain holding company strategy." We will learn how they plan to operate in crypto. They will also use new communication channels. These include their X (Twitter) account and LinkedIn page. They will still use SEC filings and press releases to update investors.
• Long-term: This event could start a new chapter for the company. It will operate fully within the volatile, fast-changing crypto market. Its success depends on its ability to carry out its stablecoin development. It also depends on its crypto investment strategies. This is especially true for the Sky Protocol and its USDS stablecoin.

7. What should investors/traders know?

Alright, for those of us watching the stock, here's the lowdown:

• This is a full business change, not just a new product. NovaBay is becoming a new company in a new industry. Its focus shifts from drugs to digital assets.
• Do your homework (again!): If you plan to hold or buy, learn about "stablecoin development," "SKY tokens," "staking," and the "Sky Protocol." This is a very different business from pharmaceuticals. For example, the Sky Protocol is a digital finance platform. It grew from MakerDAO. It lets people create USDS, a stablecoin linked to the U.S. dollar. SKY is its voting token. The protocol makes money, which buys back SKY tokens for those who stake them.
• Watch the stock's reaction: Watch how the market takes this news. Such a big change often causes huge price swings. The market will re-evaluate the company's new risk and reward.
• Consider the bigger picture: Does this crypto move fit your investment goals and risk comfort? Crypto can be far more volatile than traditional markets. Prices swing wildly due to sentiment, regulations, and tech changes. The company has steps to manage selling pressure from new investors. Still, the crypto market itself stays unpredictable.
• Re-think your investment reasons: Your reasons for investing in NovaBay Pharmaceuticals are likely no longer valid for Stablecoin Development Corporation. Remember, SKY is the only digital asset approved under their rules. This ties their future closely to this one ecosystem.
• Institutional Confidence: Major crypto players like Tether Investments joined the $134 million funding. This could signal confidence in SDEV's new path and the Sky Protocol. It might show belief in its long-term success.

This is just the initial read, so keep an eye out for more information as it comes!